BY KARA NEWBURY | FEBRUARY 2018
In the CY 2018 OPPS/ASC proposed rule, CMS also sought responses to whether the agency should consider removing THA and PHA from the IPO list.
To read this article, you have to be a member of ASCA or subscribe to ASC Focus magazine.
Already a member or subscriber? Sign in.
To become a member, click here. To subscribe to ASC Focus, click here.